Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1920 ARTÍCULOS , VIENDO DEL 16 AL 30

Pre-clinical Evidence-based Neuroprotective Potential of Naringin against Alzheimer's Disease-like Pathology: A Comprehensive Review

Singh A, Kumar Singh N.

Curr Pharm Biotechnol. 2024;25(9):1112-1123. doi: 10.2174/1389201024666230801095526.

Role of Thioredoxin System in Regulating Cellular Redox Status in Alzheimer's Disease

Qaiser H, Uzair M, Al-Regaiey K, Rafiq S, Arshad M, Yoo WK, Arain OZ, Kaleem I, Abualait T, Wang L, Wang R, Bashir S.

J Alzheimers Dis. 2024;99(s1):S97-S108. doi: 10.3233/JAD-230394.

The Role of Glial Cells in Synaptic Dysfunction: Insights into Alzheimer's Disease Mechanisms

Yu Y, Chen R, Mao K, Deng M, Li Z.

Aging Dis. 2024 Apr 1;15(2):459-479. doi: 10.14336/AD.2023.0718.

Myelin Pathology in Alzheimer's Disease: Potential Therapeutic Opportunities

Huang Z, Jordan JD, Zhang Q.

Aging Dis. 2024 Apr 1;15(2):698-713. doi: 10.14336/AD.2023.0628.

The Alzheimer's Disease Brain, Its Microvasculature, and NADPH Oxidase

Mamelak M.

J Alzheimers Dis. 2024;99(s1):S109-S118. doi: 10.3233/JAD-230415.

Deciphering the Role of Peroxisome Proliferator-activated Receptor α and Phosphodiesterase Type 5 Targets in Alzheimer's Disease

Sose PM, Kale PP, Doshi GM.

CNS Neurol Disord Drug Targets. 2024;23(8):956-970. doi: 10.2174/1871527323666230904150841.

Pharmacological Potential of Bioactive Peptides for the Treatment of Diseases Associated with Alzheimer's and Brain Disorders

Gupta JK, Singh K.

Curr Mol Med. 2024;24(8):962-979. doi: 10.2174/1566524023666230907115753.

Role of BDNF Signaling in the Neuroprotective and Memory-enhancing Effects of Flavonoids in Alzheimer's Disease

Amidfar M, Garcez ML, Askari G, Bagherniya M, Khorvash F, Golpour-Hamedani S, de Oliveira J.

CNS Neurol Disord Drug Targets. 2024;23(8):984-995. doi: 10.2174/1871527323666230912090856.

Microbiota-Gut-Brain Axis Dysregulation in Alzheimer's Disease: Multi-Pathway Effects and Therapeutic Potential

Qu L, Li Y, Liu F, Fang Y, He J, Ma J, Xu T, Wang L, Lei P, Dong H, Jin L, Yang Q, Wu W, Sun D.

Aging Dis. 2024 May 7;15(3):1108-1131. doi: 10.14336/AD.2023.0823-2.

Improving Clinical Trials of Antioxidants in Alzheimer's Disease

Daly T.

J Alzheimers Dis. 2024;99(s1):S171-S181. doi: 10.3233/JAD-230308.

Microglia and Astrocytes in Alzheimer's Disease: Significance and Summary of Recent Advances

Deng Q, Wu C, Parker E, Liu TC, Duan R, Yang L.

Aging Dis. 2024 Aug 1;15(4):1537-1564. doi: 10.14336/AD.2023.0907.

Gamma Secretase as an Important Drug Target for Management of Alzheimer's Disease: A Comprehensive Review

Hakem FT, Fouad YF, Arafa RK.

Curr Top Med Chem. 2024;24(2):109-127. doi: 10.2174/0115680266259174231006070637.

Oxidative damage in neurodegeneration: roles in the pathogenesis and progression of Alzheimer disease

Perluigi M, Di Domenico F, Butterfield DA.

Physiol Rev. 2024 Jan 1;104(1):103-197. doi: 10.1152/physrev.00030.2022.

Recent Advancements in the Treatment of Alzheimer's Disease: A Multitarget-directed Ligand Approach

Kumar S, Mahajan A, Ambatwar R, Khatik GL.

Curr Med Chem. 2024;31(37):6032-6062. doi: 10.2174/0109298673264076230921065945.

Potential Neuroprotective Strategies using Smart Drug Delivery Systems for Alzheimer's Disease

Khan J, Yadav S, Alam MA.

Infect Disord Drug Targets. 2024;24(3):e231023222565. doi: 10.2174/0118715265254985231012065058.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias